Skip to content

ALPHASURYA

Active
Private limited companyfounded 2007active for 19 yearsDe Keyserhoeve 7, 2040 Antwerpen, BelgiumKBO/BCE: BE 0893.037.329
Summary

ALPHASURYA has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €109,600 and a net result of -€6,332. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 89% of 2,144 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.7% (low).

Financials · financial year 2024, abbreviated format

2025 annual accounts not yet filed, deadline passed on 31 July 2026 Financial year closed on 31 December 2025; filing due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 31 October 2026.

Turnover
€99,880▼ 20.0%
2020 · €124,819
EBIT margin
17.2%▼ 6.9pp
2020 · 24.1%
Net result
-€6,332
2023 · €26,164
Working capital
€104,458▼ 4.5%
2023 · €109,392
Trend over the years

2020 to 2024, 5 financial years 2018 to 2024, 7 financial years

The operating result turns negative in 2024: a loss of €782 after €30,867 in 2023, the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Turnover€99,880 2021 Operating result-€782 2024 Net result-€6,332 2024

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2018201920202021202220232024
Turnover€64,247-€84,988▲ 32.3%€124,819▲ 46.9%€99,880▼ 20.0%
Operating result€5,633-€5,800▲ 3.0%€30,080▲ 419%€17,149▼ 43.0%€17,994▲ 4.9%€30,867▲ 71.5%-€782
Net result€2,233-€2,830▲ 26.7%€28,328within the sector's middle half▲ 901%€14,922below the sector's middle half▼ 47.3%€9,935below the sector's middle half▼ 33.4%€26,164below the sector's middle half▲ 163%-€6,332below the sector's middle half
EBIT margin8.8%-6.8%▼ 1.9pp24.1%▲ 17.3pp17.2%▼ 6.9pp
Equity€41,753-€44,583▲ 6.8%€64,911below the sector's middle half▲ 45.6%€79,833below the sector's middle half▲ 23.0%€89,768below the sector's middle half▲ 12.4%€115,932below the sector's middle half▲ 29.1%€109,600below the sector's middle half▼ 5.5%
Total assets€50,860-€50,484▼ 0.7%€67,536below the sector's middle half▲ 33.8%€84,949below the sector's middle half▲ 25.8%€93,837below the sector's middle half▲ 10.5%€121,130below the sector's middle half▲ 29.1%€117,805below the sector's middle half▼ 2.7%
Debt€9,107-€5,901▼ 35.2%€2,625▼ 55.5%€5,116▲ 94.9%€4,069▼ 20.5%€5,198▲ 27.7%€8,205▲ 57.8%
Working capital€38,604-€42,257▲ 9.5%€62,933within the sector's middle half▲ 48.9%€77,181within the sector's middle half▲ 22.6%€87,473within the sector's middle half▲ 13.3%€109,392within the sector's middle half▲ 25.1%€104,458within the sector's middle half▼ 4.5%
Solvency82.1%-88.3%▲ 6.2pp96.1%above the sector's middle half▲ 7.8pp94.0%above the sector's middle half▼ 2.1pp95.7%above the sector's middle half▲ 1.7pp95.7%above the sector's middle half=93.0%above the sector's middle half▼ 2.7pp
Current ratio5.24-8.16▲ 2.9224.97above the sector's middle half▲ 16.8116.09above the sector's middle half▼ 8.8922.50above the sector's middle half▲ 6.4122.05above the sector's middle half▼ 0.4513.73above the sector's middle half▼ 8.31
Return on assets (ROA)4.4%-5.6%▲ 1.2pp41.9%above the sector's middle half▲ 36.3pp17.6%within the sector's middle half▼ 24.4pp10.6%within the sector's middle half▼ 7.0pp21.6%within the sector's middle half▲ 11.0pp-5.4%below the sector's middle half▼ 27.0pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €117,805
Fixed assets €5,142 ▼ 21.4%
Current assets €112,663 ▼ 1.7%
Equity and liabilities €117,805
Equity €109,600 ▼ 5.5%
Debt €8,205 ▲ 57.8%
Debt's share of the balance-sheet total rises from 4.3% to 7.0%. Equity is lower and debt is higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€1,317▼
2023 · €32,826
Cash flow
-€4,233▼
2023 · €28,123
Quick ratio
12.97▼
2023 · 21.37
Debt to equity
0.07▲
2023 · 0.04
ROE
-5.8%▼
2023 · 22.6%
Interest coverage
6.97▼
2023 · over 100
Debt ≤ 1 year
€8,205▲
2023 · €5,198
Income taxes
€8,488▲
2023 · €4,675
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,908 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 90.9% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss
1.1% went bankrupt
7.8% stopped otherwise
90.9% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.7% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,908 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 41 lines
Balance sheet Code20232024
Assets
Total assets20/58€121,130€117,805▼
Fixed assets21/28€6,540€5,142▼
Tangible fixed assets22/27€6,540€5,142▼
Plant, machinery and equipment23€6,540€5,142▼
Current assets29/58€114,590€112,663▼
Stocks and contracts in progress3€3,505€6,254▲
Stocks30/36€3,505€6,254▲
Amounts receivable within one year40/41€99,877€83,883▼
Trade receivables40€56,920€48,032▼
Other amounts receivable41€42,957€35,851▼
Cash at bank and in hand54/58€11,208€22,526▲
Equity and liabilities
Total equity and liabilities10/49€121,130€117,805▼
Equity10/15€115,932€109,600▼
Contributions10/11€18,600€18,600=
Capital10€18,600€18,600=
Issued capital100€18,600€18,600=
Reserves13€1,860€1,860=
Non-distributable reserves130/1€1,860€1,860=
Legal reserve130€1,860€1,860=
Profit (loss) carried forward14€95,472€89,140▼
Amounts payable17/49€5,198€8,205▲
Amounts payable within one year42/48€5,198€8,205▲
Trade debts44€526€5,532▲
Suppliers440/4€526€5,532▲
Taxes, remuneration and social security45€4,672€2,673▼
Taxes450/3€272€2,673▲
Remuneration and social security454/9€4,400-
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,959€2,099▲
Other operating charges640/8€553€318▼
Gross operating margin9900€33,379€1,635▼
Operating profit (loss)9901€30,867-€782▼
Financial income75/76B-€3,127
Recurring financial income75-€3,127
Financial charges65/66B€28€189▲
Recurring financial charges65€28€189▲
Profit (loss) for the period before taxes9903€30,839€2,156▼
Income taxes67/77€4,675€8,488▲
Profit (loss) for the period9904€26,164-€6,332▼
Profit (loss) for the period to be appropriated9905€26,164-€6,332▼
Appropriation of the result
Profit (loss) to be appropriated9906€95,472€89,140▼
Profit (loss) brought forward from the previous period14P€69,308€95,472▲

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021202220232024Change
Turnover70€64,247€84,988€124,819€99,880----
Goods, raw materials, services and sundry goods60/61---€81,253----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,285€1,400€1,073€1,177€1,382€1,959€2,099▲ 7.1%
Other operating charges640/8---€301€475€553€318▼ 42.5%
Gross operating margin9900€7,499€7,789€31,695€18,627€19,851€33,379€1,635▼ 95.1%
Operating profit (loss)9901€5,633€5,800€30,080€17,149€17,994€30,867-€782-
Financial income75/76B------€3,127-
Recurring financial income75------€3,127-
Financial charges65/66B---€250€86€28€189▲ 575%
Recurring financial charges65€125€13€53€250€86€28€189▲ 575%
Profit (loss) for the period before taxes9903€5,508€5,787€30,027€16,899€17,908€30,839€2,156▼ 93.0%
Income taxes67/77€3,275€2,957€1,699€1,977€7,973€4,675€8,488▲ 81.6%
Profit (loss) for the period9904€2,233€2,830€28,328€14,922€9,935€26,164-€6,332-
Profit (loss) for the period to be appropriated9905€2,233€2,830€28,328€14,922€9,935€26,164-€6,332-
Line2018201920202021202220232024Change
Assets
Total assets20/58€50,860€50,484€67,536€84,949€93,837€121,130€117,805▼ 2.7%
Fixed assets21/28€3,149€2,326€1,978€2,652€2,295€6,540€5,142▼ 21.4%
Tangible fixed assets22/27€3,149€2,326€1,978€2,652€2,295€6,540€5,142▼ 21.4%
Land and buildings22---€1,022----
Plant, machinery and equipment23---€1,189€2,295€6,540€5,142▼ 21.4%
Furniture and vehicles24---€441----
Current assets29/58€47,711€48,158€65,558€82,297€91,542€114,590€112,663▼ 1.7%
Stocks and contracts in progress3€12,651€19,936€4,510€3,860€4,649€3,505€6,254▲ 78.4%
Stocks30/36---€3,860€4,649€3,505€6,254▲ 78.4%
Amounts receivable within one year40/41€25,065€21,977€40,822€64,718€76,595€99,877€83,883▼ 16.0%
Trade receivables40---€24,800€30,191€56,920€48,032▼ 15.6%
Other amounts receivable41---€39,918€46,404€42,957€35,851▼ 16.5%
Cash at bank and in hand54/58€9,995€6,245€20,226€13,719€10,298€11,208€22,526▲ 101%
Equity and liabilities
Total equity and liabilities10/49€50,860€50,484€67,536€84,949€93,837€121,130€117,805▼ 2.7%
Equity10/15€41,753€44,583€64,911€79,833€89,768€115,932€109,600▼ 5.5%
Contributions10/11€18,600€18,600€18,600€18,600€18,600€18,600€18,600=
Capital10---€18,600€18,600€18,600€18,600=
Issued capital100---€18,600€18,600€18,600€18,600=
Reserves13€1,860€1,860€1,860€1,860€1,860€1,860€1,860=
Non-distributable reserves130/1---€1,860€1,860€1,860€1,860=
Legal reserve130---€1,860€1,860€1,860€1,860=
Profit (loss) carried forward14€21,293€24,123€44,451€59,373€69,308€95,472€89,140▼ 6.6%
Amounts payable17/49€9,107€5,901€2,625€5,116€4,069€5,198€8,205▲ 57.8%
Amounts payable within one year42/48€9,107€5,901€2,625€5,116€4,069€5,198€8,205▲ 57.8%
Trade debts44€1,656€298€2,119€3,267€1,966€526€5,532▲ 952%
Suppliers440/4---€3,267€1,966€526€5,532▲ 952%
Taxes, remuneration and social security45---€1,849€2,103€4,672€2,673▼ 42.8%
Taxes450/3---€1,849€1,303€272€2,673▲ 883%
Remuneration and social security454/9----€800€4,400--
Line2018201920202021202220232024Change
Profit (loss) for the period9904€2,233€2,830€28,328€14,922€9,935€26,164-€6,332-
+ Depreciation and write-downs630€1,285€1,400€1,073€1,177€1,382€1,959€2,099▲ 7.1%
Operating cash flow (approximation)€3,518€4,230€29,401€16,099€11,317€28,123-€4,233-
Investment in fixed assets (approximation)--€577-€725-€1,851-€1,025-€6,204-€701▲ 88.7%
Change in cash--€3,750€13,981-€6,507-€3,421€910€11,318▲ 12×

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 17 filings with the National Bank
Financial year Type Filed Reference
31-12-2024 abbreviated format 14-08-2025 2025-00380702
31-12-2023 abbreviated format 05-11-2024 2024-00530252
31-12-2022 abbreviated format 30-08-2023 2023-00402960
31-12-2021 abbreviated format 23-08-2022 2022-20326792
31-12-2020 abbreviated format 23-08-2021 2021-52800272
31-12-2019 abbreviated format 04-08-2020 2020-39600334
31-12-2018 abbreviated format 23-08-2019 2019-50100527
31-12-2017 abbreviated format 13-08-2018 2018-45700301
31-12-2016 abbreviated format 29-05-2017 2017-13700243
31-12-2015 abbreviated format 31-08-2016 2016-55000402

Show all 17 filings

Similar companies · same sector, comparable size

Of the 974 active companies whose main activity is non-conventional therapeutic services (NACE 86961), figures are known for 10. 6 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.